Harlan Robins made a discovery 10 years ago that would change his life, his brother’s life, and potentially the lives of millions of cancer patients.
That idea is now worth $1 billion.
Adaptive Biotechnologies’ immunosequencing technology is being used by most major cancer research centers and biotech companies that are developing cancer drugs across the country. Puget Sound-area customers include the University of Washington, Fred Hutchinson Cancer Research Center, Juno Therapeutics, Seattle…
Harlan Robins made a discovery 10 years ago that would change his life, his brother’s life, and potentially the lives of millions of cancer patients.
That idea is now worth $1 billion.
Adaptive Biotechnologies’ immunosequencing technology is being used by most major cancer research centers and biotech companies that are developing cancer drugs across the country. Puget Sound-area customers include the University of Washington, Fred Hutchinson Cancer Research Center, Juno Therapeutics, Seattle…